PharmExec Picks:
Having trouble viewing this e-mail? Click here.
feed back  
Update My Profile | Advertise With Us | Visit PharmExec.com | SUBSCRIBE

Pharm Exec Picks is a biweekly eletter that delivers the most popular news and articles from the pharma space and highlights what’s trending on social media.
Top 5 Stories :
Hillary's History on Rx Price Controls
Tom Norton takes a look back on where we can find Hillary Clinton's stand on this important issue.

Read more

 

 
A New Era in Precision Gene Editing
Instead of simply being able to “read” our genes, practitioners will be able to adapt and modify DNA sequencing in living cells to treat, cure, and even prevent disease.
Read more

 

 
FDA Slow to Tackle Free Speech Challenges
FDA officials said more than a year ago that they would hold a public meeting to discuss agency policy related to industry “speech” on regulated products.
Read more

 

 
Competitive Trial Management: Winning with Clinical Studies
The EMPA-REG Outcome trial and its unprecedented results raise important questions for a myriad of stakeholders, including regulators, clinicians, patients, payers, professional associations, and pharma competitors.
Read more

 

 
China Resilient in Pharma Survey
Despite some structural concerns in the context of slowing macro-economic growth overall, the report offers a very positive outlook on prospects for the industry in China.
Read more

 
Follow Us
 
Trending on Social Media :
CPhI Experts Highlight Importance of Generics, Biosimilars Access
The pharma industry is disappointed with the outcome of the recent Transatlantic Trade and Investment Partnership talks, which limits patent exclusivity on innovative drugs and biologics in TTIP countries.
Read more

Daiichi Sankyo to Cut 1200 US Jobs
Reductions will occur in the home office in Parsippany, NJ and field-based sales.
Read more

Pharma Boards in the Era of Hostile Takeovers
With hostile takeovers on the rise, Mike Straw argues that pharma boards have a huge role to play in managing the people issues.
Read more